Rosacea treatment is a marathon — not a sprint — and there’s a need for increased emphasis on a patient-centric approach to ...

The National Rosacea Society has opened its applications for research funding as the grant program celebrates its 25th ...

While in high school, I finally took the initiative to find answers for my condition, and that's when my dermatologist told me about rosacea. Rosacea is a chronic skin condition characterized by ...

Vascular rosacea causes skin discoloration in the central area of the face that may come and go. Topical treatments and lifestyle measures can help, including avoiding things that trigger a flare-up.

Rosacea is more common among fair-skinned people ages 30 to 50 years. It's slightly more common in females rather than males. Even so, rosacea can develop at any age, even during childhood. These ...

Macular telangiectasia, sometimes referred to as idiopathic juxtafoveal macular telangiectasia, is a disease that affects the part of the eye called the macula, causing degradation or loss of central ...

Encelto, the first FDA-approved treatment for MacTel, is implanted intravitreally during a surgery performed by a qualified ophthalmologist. The Food and Drug Administration (FDA) has approved ...

Journey Medical plans to highlight the launch of Emrosi™ and showcase its line of prescription dermatology products. The FDA approved Emrosi for the treatment of inflammatory lesions of rosacea in ...

Living with skin that’s prone to rosacea isn’t easy. Trying to pin down a trigger for your redness can be exhausting: It could be stress, extreme temperatures, spicy foods, fragrance ...

Revakinagene taroretcel-lwey (Encelto; Neurotech), an allogeneic encapsulated cell-based gene therapy, is the first therapy to be approved for macular telangiectasia type 2. The FDA approved ...

Department of Dermatology, First Affiliated Hospital of Kunming Medical University, 295 Xichang Road, Kunming 650032, Yunnan, China ...